[New post] DBS: Shandong Weigao – BUY TP HK$17.70

alanyeo posted: " In-Depth Analysis: Shandong Weigao (1066 HK, BUY): FY21 earnings below consensus by 9% FY21 earnings of Rmb2.24bn below consensus by 9% due to one-off litigation claim of Rmb523m.FY21 revenue of Rmb13bn up 13.2% y-o-y, in-line with consensus.With net " New post on Alpha Edge Investing DBS: Shandong Weigao – BUY TP HK$17.70 by alanyeo In-Depth Analysis: Shandong Weigao (1066 HK, BUY): FY21 earnings below consensus by 9% FY21 earnings of Rmb2.24bn below consensus by 9% due to one-off litigation claim of Rmb523m. FY21 revenue of Rmb13bn up 13.2% y-o-y, in-line with consensus. With net cash of HK$3bn as of Dec 2021, balance sheet remains healthy  After share price correction […] Read more of this post alanyeo | March 31, 2022 at 4:03 pm | Tags: Shandong Weigao Group Medical Polymer | Categories: Equities - Research Reports by Brokers/ Banks | URL: https://wp.me/p7fA1-91Y Comment    See all comments Unsubscribe to no longer receive posts from Alpha Edge Investing. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://alphaedgeinvesting.com/2022/03/31/dbs-shandong-weigao-buy-tp-hk17-70/